Patents by Inventor Andrew Keith Forrest

Andrew Keith Forrest has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Macrolones—amino substituted quinolones
    Patent number: 7718621
    Abstract: A compound of formula (I) or a pharmaceutically acceptable derivative thereof, having antimicrobial activity, processes for their preparation, compositions containing them and to their use in medicine.
    Type: Grant
    Filed: November 9, 2005
    Date of Patent: May 18, 2010
    Assignees: Glaxo Group Ltd., Pliva-Istrazivacki Institut
    Inventors: Desmond John Best, John Stephen Elder, Andrew Keith Forrest, Robert John Sheppard, Andrea Fajdetic
  • 14 and 15 membered ring compounds
    Patent number: 7569550
    Abstract: The present invention relates to 14- or 15-membered macrolides substituted at the 4? position of formula (I) and pharmaceutically acceptable derivatives thereof, to processes for their preparation and their use in therapy or prophylaxis of systemic or topical microbial infections in a human or animal body.
    Type: Grant
    Filed: May 11, 2004
    Date of Patent: August 4, 2009
    Assignees: Glaxo Group Limited, Pliva-Istrazivacki Institut
    Inventors: Sulejman Alihodzic, Andrew Keith Forrest, Richard Lewis Jarvest, Gorjana Lazarevski, Drazen Pavlovic
  • Ether linked macrolides useful for the treatment of microbial infections
    Patent number: 7547679
    Abstract: The present invention relates to 14- or 15-membered macrolides substituted at the 4? position of formula (I) and pharmaceutically acceptable derivatives thereof, to processes for their preparation and their use in therapy or prophylaxis of systemic or topical microbial infections in a human or animal body.
    Type: Grant
    Filed: May 9, 2006
    Date of Patent: June 16, 2009
    Assignees: GlaxoSmithKline istrazivacki center Zagreb d.o.o, Glaxo Group Limited
    Inventors: Sulejman Alihodzic, Drazen Pavlovic, Eric Hunt, Andrew Keith Forrest, Ivana Palej, Samra Kapic, Vlado Stimac
  • MACROLONE COMPOUNDS
    Publication number: 20090062218
    Abstract: A compound of formula (I) compositions comprising same, processes for their preparation and use of said compounds, particularly in the treatment of microbial infections.
    Type: Application
    Filed: November 9, 2005
    Publication date: March 5, 2009
    Applicant: GLAXO GROUP LIMITED
    Inventors: Andrew Keith Forrest, Robert John Sheppard
  • 4''-Substituted Erythromycin Derivative
    Publication number: 20080269146
    Abstract: A compound of formula (I) and/or pharmaceutically acceptable derivatives thereof, having antimicrobial activity, processes for their preparation, compositions containing them and to their use in medicine.
    Type: Application
    Filed: November 7, 2006
    Publication date: October 30, 2008
    Inventors: John Stephen Elder, Andrew Keith Forrest, Eric Hunt
  • Pleuromutilin derivatives
    Patent number: 7160907
    Abstract: Pleuromutilin compounds of the formula: are of use in anti-bacterial therapy.
    Type: Grant
    Filed: December 3, 2004
    Date of Patent: January 9, 2007
    Assignee: SmithKline Beecham P.L.C.
    Inventors: John Stephen Elder, Andrew Keith Forrest, Richard Lewis Jarvest, Robert John Sheppard
  • Pleuromutilin derivatives
    Patent number: 6900345
    Abstract: Pleuromutilin compounds of the formula: are of use in anti-bacterial therapy.
    Type: Grant
    Filed: October 8, 2001
    Date of Patent: May 31, 2005
    Assignee: SmithKline Beecham p.l.c.
    Inventors: John Stephen Elder, Andrew Keith Forrest, Richard Lewis Jarvest, Robert John Sheppard
  • Novel pleuromutilin derivatives
    Publication number: 20040024059
    Abstract: Pleuromutilin compounds of the formula (A) & (B) are of use in anti-bacterial therapy.
    Type: Application
    Filed: July 25, 2003
    Publication date: February 5, 2004
    Inventors: John Stephen Elder, Andrew Keith Forrest, Richard Lewis Jarvest, Robert John Sheppard
  • Quinolones used as MRS inhibitors and bactericides
    Patent number: 6320051
    Abstract: Compounds of formula (I) are inhibitors of the bacterial enzyme S aureus methionyl tRNA synthetase and are of use in treating bacterial infections.
    Type: Grant
    Filed: October 26, 2000
    Date of Patent: November 20, 2001
    Assignee: SmithKline Beecham plc
    Inventors: John Michael Berge, Pamela Brown, John Stephen Elder, Andrew Keith Forrest, Dieter Wolfgang Hamprecht, Richard Lewis Jarvest, David Jonathan McNair, Robert John Sheppard